NYSE:AMPE Ampio Pharmaceuticals (AMPE) Stock Price, News & Analysis → The “Next Bitcoin”? 10 CENT Crypto Set to Explode (From True Market Insiders) (Ad) Free AMPE Stock Alerts $0.32 -0.03 (-8.55%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$0.32▼$0.3550-Day Range$0.24▼$2.3052-Week Range$0.14▼$8.30Volume643 shsAverage Volume31,440 shsMarket Capitalization$365,940.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsSocial Media Get Ampio Pharmaceuticals alerts: Email Address Ad Prosper Trading AcademyThis AI Trade Machine Made 1,729%* (With 89% Wins)This A.I. trading software called out an options trade the other day with a nearly perfect historical win rate… And a cumulative gain of 1729%. How does it all work?Click Here To Get Your Free Copy About Ampio Pharmaceuticals Stock (NYSE:AMPE)Ampio Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.Read More AMPE Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AMPE Stock News HeadlinesApril 21, 2024 | americanbankingnews.comAmpio Pharmaceuticals (NYSE:AMPE) Receives New Coverage from Analysts at StockNews.comApril 3, 2024 | finance.yahoo.comAmpio Pharmaceuticals Received Audit Opinion with Going Concern ExplanationApril 28, 2024 | Colonial Metals (Ad)Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. April 3, 2024 | prnewswire.comAmpio Pharmaceuticals Received Audit Opinion with Going Concern ExplanationMarch 27, 2024 | investorplace.comAMPE Stock Earnings: Ampio Pharmaceuticals Reported Results for Q4 2023March 26, 2024 | money.usnews.comAmpio Pharmaceuticals IncMarch 26, 2024 | finanznachrichten.deAmpio Pharmaceuticals, Inc.: Ampio Announces Voluntary Delisting and SEC DeregistrationMarch 26, 2024 | msn.comUS Futures Trend Higher Ahead of Durable Goods, House Prices, Consumer Confidence ReadingsApril 28, 2024 | Colonial Metals (Ad)Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. March 25, 2024 | finance.yahoo.comAmpio Announces Voluntary Delisting and SEC DeregistrationFebruary 29, 2024 | msn.comAmpio Pharmaceuticals, Ironwood, Incannex among healthcare moversFebruary 15, 2024 | finanznachrichten.deAmpio Pharmaceuticals, Inc.: Ampio Provides Update on Results from Pre-IND Enabling StudiesFebruary 14, 2024 | prnewswire.comAmpio Provides Update on Results from Pre-IND Enabling StudiesJanuary 26, 2024 | msn.comAmpio Pharmaceuticals Announces At-The-Market Stock OfferingDecember 28, 2023 | seekingalpha.comSociedad Quimica Y Minera de Chile, Altice USA, Cingulate among premarket gainers' packDecember 1, 2023 | msn.comWhat's Going On With Ampio Pharmaceuticals Stock?December 1, 2023 | msn.comRedhill Biopharma, Ampio Pharmaceuticals among healthcare moversNovember 30, 2023 | benzinga.comThinking about buying stock in Aditxt Inc, Ampio Pharmaceuticals, TOP SHIPS, Mullen Automotive, or Oatly GroupOctober 5, 2023 | finance.yahoo.comAmpio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO Services to Support Clinical Development of OA-201October 4, 2023 | finance.yahoo.comPresenting on the Emerging Growth Conference 63 Day 2 on October 5 Register NowSeptember 26, 2023 | finance.yahoo.comAmpio Pharmaceuticals to Present at the Emerging Growth ConferenceSeptember 7, 2023 | thestreet.comAmpio Pharmaceuticals (AMPE) Stock Tanks Today after Treatment Fails To Reach Primary EndpointAugust 31, 2023 | seekingalpha.comAmpio Pharmaceuticals announces 20-to-1 reverse stock splitAugust 31, 2023 | markets.businessinsider.comAmpio Pharmaceuticals Board Approves Reverse Stock Split - Quick FactsAugust 31, 2023 | finance.yahoo.comAmpio Pharmaceuticals Announces Reverse Stock SplitAugust 3, 2023 | benzinga.comThinking about buying stock in Wavedancer, Urogen Pharma, Ampio Pharmaceuticals, Innoviz Technologies, or Rigetti Computing?June 22, 2023 | msn.com3 Biotech Stocks to Buy With Explosive Upside PotentialSee More Headlines Receive AMPE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ampio Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/27/2024Today4/27/2024Next Earnings (Estimated)5/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNYSE:AMPE CUSIPN/A CIK1411906 Webampiopharma.com Phone720-437-6500Fax720-437-6501Employees6Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($11.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-8,630,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-149.00% Return on Assets-103.79% Debt Debt-to-Equity RatioN/A Current Ratio2.41 Quick Ratio2.41 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$4.04 per share Price / Book0.08Miscellaneous Outstanding Shares1,140,000Free Float1,098,000Market Cap$365,940.00 OptionableNo Data Beta1.95 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. Michael A. Martino (Age 67)CEO & Director Comp: $550kMr. Daniel G. Stokely CPA (Age 60)CFO, Corporate Secretary & Treasurer Comp: $338.31kDr. David Bar-Or M.D. (Age 75)Founder & Chairman of Scientific Advisory Board Comp: $145.6kApril RamirezClinical Trial ManagerKey CompetitorsAllarity TherapeuticsNASDAQ:ALLRChina SXT PharmaceuticalsNASDAQ:SXTCAptevo TherapeuticsNASDAQ:APVOAditxtNASDAQ:ADTXObsEvaNASDAQ:OBSVView All CompetitorsInsidersJ Kevin BuchiBought 1,250 shares on 6/8/2023Total: $7,500.00 ($6.00/share)Michael A MartinoBought 3,844 shares on 5/24/2023Total: $22,295.20 ($5.80/share)David R StevensBought 2,500 shares on 5/11/2023Total: $11,000.00 ($4.40/share)View All Insider Transactions AMPE Stock Analysis - Frequently Asked Questions How have AMPE shares performed in 2024? Ampio Pharmaceuticals' stock was trading at $2.05 at the start of the year. Since then, AMPE stock has decreased by 84.3% and is now trading at $0.3210. View the best growth stocks for 2024 here. When is Ampio Pharmaceuticals' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 13th 2024. View our AMPE earnings forecast. How were Ampio Pharmaceuticals' earnings last quarter? Ampio Pharmaceuticals, Inc. (NYSE:AMPE) announced its quarterly earnings results on Wednesday, March, 27th. The company reported ($2.48) EPS for the quarter. When did Ampio Pharmaceuticals' stock split? Shares of Ampio Pharmaceuticals reverse split before market open on Tuesday, September 12th 2023. The 1-20 reverse split was announced on Thursday, August 31st 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, September 11th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. What other stocks do shareholders of Ampio Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Ampio Pharmaceuticals investors own include Tesla (TSLA), Agenus (AGEN) and American Airlines Group (AAL). How do I buy shares of Ampio Pharmaceuticals? Shares of AMPE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:AMPE) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe World's First "$20 Trillion Drug?"Behind the MarketsMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ampio Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
